Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 2001;79(5):394–399.

Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment.

K Yeboah-Antwi 1, J O Gyapong 1, I K Asare 1, G Barnish 1, D B Evans 1, S Adjei 1
PMCID: PMC2566421  PMID: 11417034

Abstract

OBJECTIVE: To examine the extent to which district health teams could reduce the burden of malaria, a continuing major cause of mortality and morbidity, in a situation where severe resource constraints existed and integrated care was provided. METHODS: Antimalarial drugs were prepackaged into unit doses in an attempt to improve compliance with full courses of chemotherapy. FINDINGS: Compliance improved by approximately 20% in both adults and children. There were 50% reductions in cost to patients, waiting time at dispensaries and drug wastage at facilities. The intervention, which tended to improve both case and drug management at facilities, was well accepted by health staff and did not involve them in additional working time. CONCLUSION: The prepackaging of antimalarials at the district level offers the prospect of improved compliance and a reduction in the spread of resistance.

Full Text

The Full Text of this article is available as a PDF (241.9 KB).


Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES